Journal of Pharmacy and Pharmacology

Electronic Submission to the Journal of Pharmacy and Pharmacology
pp. 689-689(1)
Authors: Craig D.Q.M.; Jones D.S.

Carbohydrate-based therapeutics
pp. 691-702(12)
Authors: Osborn H.M.I.; Evans P.G.; Gemmell N.; Osborne S.D.

Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[n]arenes
pp. 703-708(6)
Authors: Yang W.; de Villiers M.M.

Development and application of a micro-capillary rheometer for in-vitro evaluation of parenteral injectability
pp. 709-716(8)
Authors: Allahham A.; Mainwaring D.; Stewart P.; Marriott J.

Ion-pairs of ibuprofen: increased membrane diffusion
pp. 717-724(8)
Authors: Sarveiya V.; Templeton J.F.; Benson H.A.E.

Influence of preparation methodology on solid-state properties of an acidic drug–cyclodextrin system
pp. 725-733(9)
Authors: Govindarajan R.; Nagarsenker M.S.

Influence of dissolution media composition on drug release and in-vitro/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers
pp. 735-741(7)
Authors: Parojci J.; &Eth;uri Z.; Jovanovi M.; Ibri S.; Jovanovi D.

Acteoside protects endothelial cells against free radical-induced oxidative stress
pp. 743-748(6)
Authors: Chiou W.F.; Lin L.C.; Chen C.F.

In-vitro metabolism of isotetrandrine, a bisbenzylisoquinoline alkaloid, in rat hepatic S9 fraction by high-performance liquid chromatography–atmospheric pressure ionization mass spectrometry
pp. 749-755(7)
Authors: Wu W-N.; Mckown L.A.; Gopaul S.V.

Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4
pp. 757-768(12)
Authors: Mohamed H.E.; Asker M.E.; Ali S.I.; Abd El Fattah T.M.

5'-Deiodinase type 1 activity in liver and brain of the thyroxine-treated dystrophic hamster
pp. 769-774(6)
Authors: Singh Y.N.; Gleysteen A.L.; Ganschow S.L.

Fumigaclavine C improves concanavalin A-induced liver injury in mice mainly via inhibiting TNF- production and lymphocyte adhesion to extracellular matrices
pp. 775-782(8)
Authors: Zhao Y.; Liu J.; Wang J.; Wang L.; Yin H.; Tan R.; Biotechnology P.; School of Life Sciences; University N.; China N.2.; Xu Q.

Synthesis of (2E)-2-methyl-3-(4-{[4-(quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl)prop-2-enoic acid (VUFB 20609) and 2-methyl-3-(4-{[4-(quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl)propanoic acid (VUFB 20584) as potential antileukotrienic agents
pp. 783-794(12)
Authors: Jampílek J.; Dolezal M.; Faculty of Pharmacy in Hradec; Králove´ Charles University in; Prague; 500 05 Hradec Králove´; Republic C.; Kunes J.; Jun D.; Hanika J.; Oconnor R.; Clynes M.

Hypoglycaemic effect of Calamintha officinalis Moench. in normal and streptozotocin-induced diabetic rats
pp. 795-799(5)
Authors: Lemhadri A.; Zeggwagh N.-A.; Maghrani M.; Jouad H.; Michel J.B.; Eddouks M.

Hypochlorite scavenging activity of flavonoids
pp. 801-807(7)
Authors: Firuzi O.; Mladenka P.; Petrucci R.; Marrosu G.; Saso L.

Pharmacokinetic modulation of irinotecan metabolites by sulphobromophthalein in rats
pp. 809-812(4)
Authors: Itoh T.; Itagaki S.; Sasaki K.; Hirano T.; Takemoto I.; Iseki K.

Comparison of the synaptosomal uptake inhibition of serotonin by St John's wort products
pp. 813-818(6)
Authors: Schulte-Löbbert S.; Holoubek G.; Müller W.E.; Schubert-Zsilavecz M.; Wurglics M.

Phenacetin and chlorzoxazone biotransformation in aging male Fischer 344 rats
pp. 819-825(7)
Authors: Warrington J.S.; Court M.H.; Greenblatt D.J.; von Moltke L.L.